HOME >> MEDICINE >> NEWS
Sabin Gold Medal awarded to vaccine developer Dr. Albert Z. Kapikian

Albert Z. Kapikian, M.D., of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), was awarded the prestigious Albert B. Sabin Gold Medal at a ceremony on May 10, 2005. Cited for his "extraordinary achievements in vaccinology," Dr. Kapikian is the 13th recipient of this recognition, awarded annually by the Sabin Vaccine Institute to honor achievements by vaccinologists and infectious disease experts. In addition, John R. La Montagne, Ph.D., who served as NIAID deputy director from 1998 until his death in November 2004, was posthumously recognized at the ceremony, which was held in conjunction with the National Foundation for Infectious Diseases Eighth Annual Conference on Vaccine Research in Baltimore, MD.

Dr. Kapikian's career of more than 47 years, with groundbreaking medical research contributions, is distinguished by the development of the first licensed rotavirus vaccine.

"This well-deserved honor recognizes decades of creative research by Dr. Kapikian and his collaborators," says NIAID Director Anthony S. Fauci, M.D. "Dr. Kapikian's scientific ingenuity, perseverance and leadership, notably in the development of vaccines against rotavirus, have been remarkable."

"Albert Kapikian's contribution to mankind through the field of vaccines is truly extraordinary," says H.R. Shepherd, D.Sc., chairman of the Sabin Vaccine Institute. "It takes a great vision and dedication to achieve such progress for humanity."

In the 1950s Dr. Kapikian began studying the epidemiology and causes of various viral diseases. He is renowned for pioneering studies using electron microscopy to discover and characterize viruses causing major diseases in humans. In 1972, Dr. Kapikian identified the Norwalk virus, the first virus associated with acute epidemic gastroenteritis, gaining recognition as "the father of human gastroenteritis virus research." In 1973, he and two colleagues identified the
'"/>

Contact: NIAID News Office
niaidnews@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
12-May-2005


Page: 1 2

Related medicine news :

1. Nancy Brinker and Lance Armstrong honored with Centennial Medals at the AACR 2007 Annual Meeting
2. Cancer vaccine innovator honored with prestigious Florey Medal
3. ASTRO announces 2006 Gold Medal winners
4. Bazan to receive ARVO Proctor Medal
5. Ronald Breslow to receive 2006 Othmer Gold Medal
6. Rice bioengineer wins ASMEs Van C. Mow Medal
7. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
8. LSUHSC awarded designation resulting in improved patient safety and outcomes
9. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
10. UIC awarded $7M NIH grant for infertility research
11. $2.6M grant awarded to New York University College of Nursing

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sabin Gold Medal awarded vaccine developer Albert Kapikian

(Date:5/20/2013)... VHA Inc., the national health care ... population health improvement, announced a new offering to ... pursue population health management with a strategic ... the transition to value-based models of care. As ... of services, the offering integrates VHA expert advisory ...
(Date:5/20/2013)... have mapped the significance of heredity for common ... examined whether different forms of the disease share ... ischemic stroke, peripheral arterial disease and atherosclerosis of ... have suffered different types of cardiovascular disease. , ... atherosclerosis of the aorta followed by peripheral arterial ...
(Date:5/20/2013)... Gilman Law LLP, a leading pharmacy ... lawsuits, is troubled by a new study that reveals ... type 2 diabetes drugs are growing. The analysis, ... found that 71 Byetta pancreatic cancer reports had been ... as of June 30, 2012. Overall, Byetta ...
(Date:5/20/2013)... Newport News, VA (PRWEB) May 20, 2013 ... Jeffrey Carlson successfully performed a procedure using SpineFrontier’s FacetFuse ... Fusion Device System. The operation took place on ... Hospital in Newport News, VA. The surgery was ... a 66 year-old, female patient. , Dr. Carlson described ...
(Date:5/20/2013)... The study comprised over 24,000 Finnish subjects and ... revealed that a panel of 28 genetic markers ... coronary heart disease (CHD) (10-year risk ≥20%) over ... is an important preventive strategy for CHD, because ... high-risk group. "The results indicate that genetic markers ...
Breaking Medicine News(10 mins):Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 2Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 3Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 2Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 3
(Date:5/17/2013)... 17, 2013 Medical devices are any medical ... product. In light of their different mechanisms, actions and ... more complicated than drug trails due to their unique ... instead of evaluating both safety and efficacy (which is ... is the same as the SFDA) evaluate MDs for ...
(Date:5/17/2013)... DIEGO , May 17, 2013  Sorrento ... that its Fast-Track Advanced Technology Small Business Technology ... Institute of Allergy and Infectious Diseases (NIAID), a ... supporting the development of novel human antibody therapeutics ... aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... , May 17, 2013  Technology advances ... communicate internally. Faced with a constantly evolving communication ... and tactics for communicating with internal executives. It ... all the strategies, tactics and tools that are ... In a new study, Best Practices, LLC explores ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2
Cached News: